Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS

GLIA

Volumn 48, Issue 2, 2004, Pages 166-178

  Coleman, Elaine ^a   Judd, Robert ^a   Hoe, Lori ^a   Dennis, John ^a   Posner, Philip ^b  

^a AUBURN UNIVERSITY   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Glia; Glial fibrillary acidic protein

Indexed keywords

AMINO ACID TRANSPORTER; CARRIER PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE ASPARTATE TRANSPORTER; GLUTAMATE TRANSPORTER; INTERMEDIATE FILAMENT PROTEIN; STREPTOZOCIN; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL COUNT; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; STROKE; WESTERN BLOTTING; WHITE MATTER;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASTROCYTES; BRAIN; BRAIN DISEASES; CELL COUNT; CEREBELLUM; CEREBRAL CORTEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MALE; RATS; RATS, WISTAR;

EID: 9144227606     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20068     Document Type: Article

References (78)

1. Abbott NJ. 2002. Astrocyte-endothelial interactions and the blood-brain barrier permeability. J Anat 200:629-638.
2. Aizenman Y, de Vellis J. 1987. Synergistic action of thyroid hormone, insulin and hydrocortisone on astrocyte differentiation. Brain Res 414:301-308.
3. Al Deeb S, Al Moutaery K, Arshaduddin M, Biary N, Tariq M. 2000. Attenuation of acrylamide-induced neurotoxicity in diabetic rats. Neurotoxicol Teratol 22:247-253.
4. Andersen CM, Nedergaard M. 2003. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci 26:340-344.
5. Araque A, Parpura V, Sangiri RP, Haydon PG. 1999. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22:208-215.
6. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. 2003. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506-511.
7. Atienza G, Andres MD, Rebolledo E, Aldegunde M. 1992. Brain tryptophan uptake and sodium-potassium ATPase activity in long-term streptozotocin diabetic rats. Neurochem Res 17:289-292.
8. Barber AJ, Antonetti DA, Gardner TW. 2000. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 41:3561-3568.
9. Bauer H-C, Bauer H. 2000. Neural induction of the blood-brain barrier: still an enigma. Cell Mol Neurobiol 20:13-28.
10. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV. 2003. Increase of glial fibrillary acidic protein and S-100B in the hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462:67-71.
11. Bhardwaj SK, Sharma P, Kaur G. 1998. Alterations in free radical scavenger system profile of Type I diabetic rat brain. Mol Chem Neuropathol 35:187-202.
12. Biessels GJ, Kamal A, Urban IJA, Spruijt BM, Erkelens DW, Gispen WH. 1998. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800:125-135.
13. Bouchard P, Ghitescu LD, Bendayan M. 2002. Morpho-functional studies of the blood-brain barrier in streptozotocin-induced diabetic rats. Diabetologia 45:1017-1025.
14. Chabot C, Massicotte G, Milot M, Trudea F, Gagné J. 1997. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res 768:249-256.
15. Chehade JM, Haas MJ, Mooradian AD. 2002. Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem Res 27:249-252.
16. Chen Y, Swanson RA. 2003. Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149.
17. Coleman ES, Wooten MW. 1994. Nerve growth-factor induced differentiation of PC12 cells employs the PMA-insensitive protein kinase C-zeta isoform. J Mol Neurosci 5:1-15.
18. Culleton BF, Wilson PW. 1998. Cardiovascular disease: risk factors, secular trends, and therapeutic guidelines. J Am Soc Nephrol 9:S5-15.
19. Dennis JC, Allgier JG, Desouza LS, Eward WC, Morrison EE. 2003. Immunohistochemistry of the canine vomeronasal organ. J Anat 202:515-524.
20. Di Luca M, Ruts L, Gardoni F, Cattabeni F, Biessels, GJ, Gispen WH. 1999. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia 42:693-701.
21. Dringen R, Gutterer JM, Hirrlinger J. 2000. Glutathione metabolism in the brain. Metabolic interactions between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912-4916.
22. Dugar A, Patanow C, O'Callaghan JP, Lakoski JM. 1998. Immunohistochemical localization and quantification of glial fibrillary acidic protein and synaptosomal-associated protein (mol. wt 25000) in the ageing hippocampus following administration of 5,7-dihydroxytryptamine. Neuroscience 85:123-133.
23. Eng LF, Ghirnikar RS, Lee YL. 2000. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:1439-1451.
24. Fouyas IP, Kelly PAT, Ritchie IM, Lammie GA, Whittle IR. 2003. Cerebrovascular response to pathophysiological insult in diabetic rats. J Clin Neurosci 10:88-91.
25. Gagne J, Milot M, Gelinas S, Lahsaini A, Trudea F, Martinoli M, Massicotte G. 1997. Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes 46:841-846.
26. Gispen WH, Biessels GJ. 2000. Cognitive and synaptic plasticity in diabetes mellitus. Trends Neurosci 23:542-549.
27. Guyot LL, Diaz FG, O'Regan MH, Song D, Phillis JW. 2000. The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemia ischemia. Brain Res 872:29-36.
28. Hansson E, Muyderman H, Leonova J, Allansson L, Sinclair J, Blomstrand F, Thorlin T, Nilsson M, Rönnback L. 2000. Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap junction communication. Neurochem Int 37:317-329.
29. Hazell AS, Rao KV, Danbolt NC, Pow DV, Butterworth RF. 2001. Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy. J Neurochem 78:560-568.
30. Hertz L, Dringen R, Schousboe A, Robinson SR. 1999. Astrocytes: glutamate producers for neurons. J Neurosci Res 57:417-428.
31. Hertz L, Hansson E, Rönnbäck L. 2001. Signaling and gene expression in the neuron-glia unit during brain function and dysfunction: Holger Hyden in memoriam. Neurochem Int 39:227-252.
32. Horani MH, Mooradian AD. 2003. Effects of diabetes on the blood brain barrier. Curr Pharm Res 9:833-840.
33. Hudspith MJ. 1997. Glutamate: a role in normal brain function, anesthesia, analgesia, and CNS injury. Br J Anaesth 78:731-747.
34. Kakinuma Y, Hama H, Sugiyama F, Yagami K, Goto K, Murakami K, Fukamizu A. 1998. Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nature Med 4:1078-1080.
35. Kamal A, Biessels GJ, Duis SEJ, Gispen WH. 2000. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 43:500-506.
36. Kim HC, Im DH, Jhoo WK, Kim C, Wie MB. 1997. A low dose of streptozotocin prevents kainic acid-induced seizures and lethal effects in the rat. Clin Exp Pharmacol Physiol 24:503-505.
37. Koplan JP, 2001. Diabetes: a serious public health problem. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
38. Laming PR, Kimelberg H, Robinson S, Salm A, Hawrylak N, Müller C, Roots B, Ng K. 2000. Neuronal-glial interactions and behaviour. Neurosci Biobehav Rev 24:295-340.
39. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. 1995. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15:1835-1853.
40. Leong SF, Leung TKC. 1991. Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain. Neurochem Res 16: 1161-1165,
41. Li N, Young MM, Bailey CJ, Smith ME. 1999. NMDA and AMPA glutamate receptor subtypes in the thoracic spinal cord in lean obese-diabetic ob/ob mice. Brain Res 849:34-44.
42. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS, 1996. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17:607-615.
43. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM. 1998. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. 47:815-820.
44. Lin CY, Higginbotham DA, Judd RL, White BD. 2002. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 282:E1084-1091.
45. Mankovsky BN, Metzger BE, Molitch ME, Biller J. 1996. Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complications 10:228-242.
46. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. 1996. Targeted deletion in astrocyte intermediate filament (GFAP) alters neuronal physiology. Proc Natl Acad Sci USA 93:6361-6366.
47. McNeill JH. 1999. Experimental models of diabetes. Boca Raton, FL: CRC Press. p 3-17.
48. Melzer P, Savchenko V, McKanna JA. 2001. Microglia, astrocytes, and macrophages react differently to central and peripheral lesions in the developing and mature rat whisker-to-barrel pathway: a study usingimmunohistochemistry for lipocortin1, phosphotyrosine, S100 beta, and mannose receptors. Exp Neurol 168:63-77.
49. Mercier F, Hatten GI. 2000. Immunocytochemical basis for a meningeo-glial network. J Comp Neurol 420:445-465.
50. Newman EA. 2003. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26:536-542.
51. + ATPase activities in streptozotocin-diabetic and pentylenetetrazol-epileptic rats. Pharmacol Res 36:69-72.
52. Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB. 1999. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurol 53:1937-1942.
53. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press.
54. Pelligrino DA, Albrecht RF. 1991. Chronic hyperglycemic diabetes in the rat is associated with a selective impairment of cerebral vasodilatory responses. J Cereb Blood Flow Metab 11:667-677.
55. Popoviç M, Biessels GJ, Isaacson RL, Gispen WH. 2001. Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task. Behav Brain Res 122:201-207.
56. Prat A, Biernacki K, Wosik K, Antel JP. 2001. Glial cell influence on the blood-brain barrier. Glia 36:145-155.
57. Ransom B, Behar T, Nedergaard M. 2003. New roles for astrocytes (stars at last). Trends Neurosci 26:520-522.
58. Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ, Packer L. 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212.
59. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kunci RW. 1994. Localization of neuronal and glial glutamate transporters. Neuron 13:713-725.
60. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kunci RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
61. Rungger-Brändle E, Dosso AA, Leuenberger PM. 2000. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971-1980.
62. Saravia FE, Revsin Y, Deniselle MCG, Gonzalez SL, Roig P, Lima A, Homo-Delarche F, De Nicola AF. 2002. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 957:345-353,
63. Sharma M, Gupta YK. 2001. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 68:1021-1029.
64. Shoham S, Bejar C, Kovalev E, Weinstock M. 2003. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184:1043-1052.
65. Sorci G, Agneletti AL, Bianchi R, Donato R. 1998. Association of S100B with intermediate filaments and microtubules in glial cells. Biochim Biophys Acta 1448:277-289.
66. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. 2003. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74:70-76.
67. Tao-Cheng JH, Nagy Z, Brightman MW. 1987. Tight junctions of brain endothelium in vitro are enhanced by astroglia. J Neurosci 7:3293-3299.
68. Thomas RJ. 1997. Seizures and epilepsy in the elderly. Arch Intern Med 157:605-617.
69. Tiu SC, Yew DT, Chan WY. 2003. Development of the human cerebral cortex: a histochemical study. Prog Histochem Cytochem 38:3-149.
70. Toran-Allerand CD, Bentham W, Miranda RC, Anderson JP. 1991. Insulin influences astroglial morphology and glial fibrillary acidic protein (GFAP) expression in organotypic cultures. Brain Res 558: 296-304.
71. Travis J. 1994. Glia: the brain's other cells. Science 266:970-972.
72. Tsacopoulos M, Magistretti PJ. 1996. Metabolic coupling between glia and neurons. J Neurosci 16:877-885.
73. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. 2001. Control of synapse number by glia. Science 291:657-661.
74. +-ATPase in streptozotocin diabetic rats. Biochim Biophys Acta 1237:143-150.
75. Walz W. 2000. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem Int 36:291-300.
76. Whiting S, Camfield P, Arab D, Salisbury S. 1997. Insulin-dependent diabetes mellitus presenting in children as frequent, medically unresponsive, partial seizures. J Child Neurol 12:178-180.
77. Wilson JX. 1997. Antioxidant defense of the brain: a role for astrocytes. Can J Physiol Pharmacol 75:1149-1163.
78. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossman KA, Pozzan T, Carmignoto G. 2003. Neuron to astrocyte signaling is central to the dynamic control of brain microcirculation, Nat Neurosci 6:43-50.